Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berczi I., Sehon A. H. Tumor inhibition by effector cells cultured from progressing sarcomas. Immunol Commun. 1977;6(6):617–632. doi: 10.3109/08820137709093471. [DOI] [PubMed] [Google Scholar]
- Evans R., Booth C. G., Spencer F. Lack of correlation between in vivo rejection of syngeneic fibrosarcomas and in vitro non-specific macrophage cytotoxicity. Br J Cancer. 1978 Nov;38(5):583–590. doi: 10.1038/bjc.1978.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gillespie G. Y., Russell S. W. Development and persistence of cytolytic T lymphocytes in regressing or progressing Moloney sarcomas. Int J Cancer. 1978 Jan 15;21(1):94–99. doi: 10.1002/ijc.2910210116. [DOI] [PubMed] [Google Scholar]
- Haskill J. S., Häyry P., Radov L. A. Systemic and local immunity in allograft and cancer rejection. Contemp Top Immunobiol. 1978;8:107–170. doi: 10.1007/978-1-4684-0922-2_5. [DOI] [PubMed] [Google Scholar]
- Holden H. T., Haskill J. S., Kirchner H., Herberman R. B. Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors. J Immunol. 1976 Aug;117(2):440–446. [PubMed] [Google Scholar]
- Howell S. B., Dean J. H., Esber E. C., Llaw L. W. Cell interactions in adoptive immune rejection of a syngeneic tumor. Int J Cancer. 1974 Nov 15;14(5):662–674. doi: 10.1002/ijc.2910140514. [DOI] [PubMed] [Google Scholar]
- Moore K., Moore M. Systemic and in-situ natural killer activity in tumour-bearing rats. Br J Cancer. 1979 Jun;39(6):636–647. doi: 10.1038/bjc.1979.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Williams A. F., Galfrè G., Milstein C. Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes. Cell. 1977 Nov;12(3):663–673. doi: 10.1016/0092-8674(77)90266-5. [DOI] [PubMed] [Google Scholar]